Entities / Company
Xenon.
nightclub in New York City
- Reports this week
- 0
- Active events
- 0
- Connections
- 36
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Deutsche Bank downgraded stock and Needham cut price targets citing safety concerns regarding Xenon's product ahead of its NDA meeting.Some support1 report
-
Xenon and Coya Therapeutics are both clinical-stage biotech companies.Some support1 report
-
Xenon, a company headquartered in Canada, began trading on the Nasdaq stock exchange.Some support1 report
One to three months ago
Gone quiet
No new reports in 90+ days-
Xenon Pharmaceuticals is developing azetukalner for various conditions and has completed patient recruitment for the X-TOLE2 Phase 3 clinical trial.Some support2 reports
-
Xenon Pharmaceuticals was included in a broad-market index on June 28, 2025.Speculative1 report
-
Xenon Pharmaceuticals appointed Darren Cline as Chief Commercial Officer on June 24, 2025.Speculative1 report
-
RBC maintained an Outperform rating on Xenon Pharmaceuticals, noting Azetukalner as its top medication candidate, while Trump-era tariffs benefit AI stocks.Speculative1 report
-
Xenon Pharmaceuticals maintains offices in Vancouver and Boston.Some support7 reports
-
Xenon and Neurocrine Biosciences announced a partnership on August 12, 2025, allowing collaboration and milestone payments regarding Azetukalner, which is Xenon's lead pipeline candidate.Some support1 report
-
Xenon reported financial results from Vancouver and Boston and named Mortimer as its President and CEO.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Xenon this week
News at the entities that move Xenon most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Xenon
-
Boston StructuralThe Federal Aviation Administration is managing air traffic operations at Boston Logan Airport.Moves Xenon
-
Needham Mentioned togetherA data center project involving DeepGreen Cook Inlet is seeking preliminary permits from the FERC while facing opposition from the Kenai Peninsula Borough.Moves Xenon
-
Deutsche Bank TransactionalGeopolitical risk adds to UK fiscal pressures as renewed fighting drives up oil prices, prompting economists to analyze market impacts.Moves Xenon
-
Vancouver Shared contextA multi-city food festival was held across Vancouver, Toronto, Calgary, and Victoria, featuring Michelin recognition in Toronto.Moves Xenon
-
Nasdaq Shared contextApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Xenon
Connections
The 11 strongest of 36, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Boston Structural
Xenon is establishing and maintaining operational offices and media contacts within the city of Boston.
-
FDA Structural
FDA exercises regulatory oversight over Xenon's clinical trials and drug development processes, including filing and NDA reviews.
-
LinkedIn Operational
Xenon utilizes LinkedIn as a professional outreach and market presence platform.
-
Needham Mentioned together
Needham cut its price target for Xenon due to safety concerns.
-
Vancouver Shared context
Xenon is consistently reported as being based in or operating within the city of Vancouver, BC.
-
Nasdaq Shared context
Xenon is a company that trades on the Nasdaq stock exchange.
-
Virginia Shared context
Xenon presented its results at a conference held in Virginia.
-
Athens Shared context
Xenon presented Phase 3 data at a conference held in Athens.
Show all 11 connections
-
Deutsche Bank Transactional
The relationship is evidenced by a stock downgrade of Deutsche Bank citing safety concerns.
-
Chicago Shared context
Xenon presented results at a conference held in Chicago.
-
American Academy of Neurology Operational
Xenon presented its research results at a meeting hosted by the American Academy of Neurology.
History
Events by the month they beganSeptember 2026
3 eventsJuly 2026
1 eventJune 2026
7 events- Xenon Pharmaceuticals is developing azetukalner for various conditions and has completed patient recruitment for the X-TOLE2 Phase 3 clinical trial.
- Xenon Pharmaceuticals was included in a broad-market index on June 28, 2025.
- Xenon Pharmaceuticals appointed Darren Cline as Chief Commercial Officer on June 24, 2025.
- RBC maintained an Outperform rating on Xenon Pharmaceuticals, noting Azetukalner as its top medication candidate, while Trump-era tariffs benefit AI stocks.
- Xenon Pharmaceuticals maintains offices in Vancouver and Boston.
- Xenon and Neurocrine Biosciences announced a partnership on August 12, 2025, allowing collaboration and milestone payments regarding Azetukalner, which is Xenon's lead pipeline candidate.
- Xenon reported financial results from Vancouver and Boston and named Mortimer as its President and CEO.